glp-1 therapy weight loss specialists Physician-Led Power of GLP-1 Therapy Paired

Traditional Medicare and Medicare Advantage rules differ

L., & Sim, W

doi:10.1097/01.CCM.0000114811.60629.B5

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment

GLP-1 acts on the brain to induce feelings of satiety, thus reducing appetite and leading to weight loss

While GLP-1 medications are eligible for insurance coverage, actual coverage depends on your specific insurance plan, the drug youre being prescribed, and whether or not you meet eligibility requirements for that drug